|Education||BS, Massachusetts Institute of Technology|
Dr. Elizabeth Jaffee’s lab studies novel approaches to cancer immunotherapy, primarily in the context of pancreatic cancer. Central to the success of these therapies is the development of a repertoire of anti-tumor CD8 T cells. New sequencing approaches (TCR Sequencing) allow the measurement and tracking of these these cells with high precision. I use TCR sequencing to answer fundamental questions about the nature of successful anti-tumor vaccination in a variety of treatment settings.